We have, however, recently reported significantly higher rates of albumin-to-creatinine ratio (ACR) testing and prescription of guideline-recommended angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins in regions where the CKD-P was most actively used.30 Increased CKD-P awareness among health care providers may have contributed to improvements in CKD patient management. The gene discussed is ACE; the disease is chronic kidney disease.